Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

N/AUnknownNCT00867633

National Taiwan University Hospital100 enrolled

Overview

To study the association between aristolochic acid and urothelial carcinoma in Taiwan

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Urothelial Carcinoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * the resected kidney tissue in the tissue bank Exclusion Criteria: * the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

Outcomes

Primary Outcomes

the incidence of aristolochic-acid DNA adduct in the samples

Time frame: one week

Central Contacts

Yeong-Shiau Pu, Ph.D.

CONTACT

886-2-23123456 yspu@ntu.edu.tw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.